XBiotech Inc.
XBIT
$2.42
-$0.02-0.82%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 79.53% | -347.60% | -242.14% | 83.87% | -3.58% |
| Total Depreciation and Amortization | -12.17% | -11.48% | -2.73% | -0.68% | 0.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 230.01% | -181.81% | 141.22% | -197.67% | -35.60% |
| Change in Net Operating Assets | -211.72% | 4,655.21% | 105.65% | -350.81% | 156.46% |
| Cash from Operations | 60.92% | -438.91% | 28.89% | 10.88% | -2.75% |
| Capital Expenditure | -- | 69.09% | -115.69% | 45.74% | -11.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 126.47% | 69.09% | -115.69% | 45.74% | -11.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 100.00% | -3,721.91% |
| Foreign Exchange rate Adjustments | -196.75% | 197.34% | -139.01% | 984.86% | 106.93% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.74% | -291.60% | -88.27% | 82.37% | -60.71% |